CS585, a novel prostacyclin receptor agonist, demonstrates sustained efficacy in vivo in the prevention of thrombosis - KIVIRID

CS585, a novel prostacyclin receptor agonist, demonstrates sustained efficacy in vivo in the prevention of thrombosis

Authors: L Stanger, A Rickenberg, M Flores, B Dahlof, M Holinstat

Published: 2024-10-28

DOI: 10.1093/eurheartj/ehae666.3341

Source: Full article

Abstract

Abstract